Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mohamed Elkhalifa"'
Autor:
Martin Vogel, Muna Qayed, Shanmuganathan Chandrakasan, Sharmila Raghunandan, Melinda Pauly, William G Blum, Madhav V Dhodapkar, Mohamed Elkhalifa, Benjamin Watkins, Michelle Schoettler, Edwin Horwitz, Suhag Parikh, Kathryn Leung, Elyse Bryson, Laura Deeb, Jonathan L Kaufman, Diana Worthington-White, Adina Alazraki, Jordan M Schecter, Deepu Madduri, Carolyn C Jackson, Enrique Zudaire, Agne Taraseviciute-Morris, Alexander Babich, Tonia Nesheiwat, Nikoletta Lendvai, Lida Pacaud, Kirsten M Williams
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 5 (2023)
Plasmablastic lymphoma (PBL) is a rare subtype of aggressive large B-cell lymphoma, with a dismal prognosis despite aggressive therapies. New approaches are needed for those with refractory disease. PBL expresses antigens similar to multiple myeloma
Externí odkaz:
https://doaj.org/article/8d09210335ff4eafb1dab8feacb96d23
Publikováno v:
Medicina, Vol 59, Iss 3, p 585 (2023)
Background and Objective: Minimally Invasive Transforaminal Lumbar Interbody Fusion (MIS-TLIF) has been investigated and shown excellent short- and long-term outcomes. In this paper, we describe a new MIS-TLIF technique and pedicle screw insertion us
Externí odkaz:
https://doaj.org/article/39fc3f98bb1e4d4eb498ecdafe4ff9e6
Autor:
Cristina Interiano, Sheicho Muze, Brian Turner, Mark Gonzalez, Beverly Rogers, Robert Jerris, Elizabeth Weinzierl, Mohamed Elkhalifa, Van Leung-Pineda
Publikováno v:
Data in Brief, Vol 36, Iss , Pp 107110- (2021)
Background: SARS-CoV-2 infection in children does not seem to follow the same pattern as in adults. Limited information is published on the level of antibody production and the duration of antibody response in children with COVID-19. Moreover, it is
Externí odkaz:
https://doaj.org/article/4488cf16f8ea4341a29e236b4a0c8290
Autor:
Cristina Interiano, Sheicho Muze, Brian Turner, Mark Gonzalez, Beverly Rogers, Robert Jerris, Elizabeth Weinzierl, Mohamed Elkhalifa, Van Leung-Pineda
Publikováno v:
Practical Laboratory Medicine, Vol 25, Iss , Pp e00208- (2021)
Background: Clinical laboratory testing has been an essential part of COVID-19 management. Serology can provide valuable information regarding a patient’s exposure to virus, and may have a larger role to play as vaccines becomes available. Limited
Externí odkaz:
https://doaj.org/article/725a99384aaf49df81c03890336a0499
Autor:
Mohammed A. Khashab, Mohamed Elkhalifa
Publikováno v:
Journal of Musculoskeletal Surgery and Research. 6:213-218
Objectives: Minimal invasive spinal surgery (MISS) is a relatively new surgical approach that minimizes tissue damage, reduces blood loss, and promises faster post-operative recovery compared to the traditional open approach. The current retrospectiv
Publikováno v:
Cureus.
Publikováno v:
Clinics in Laboratory Medicine. 41:389-404
Mediastinal masses commonly present in children and may pose diagnostic challenges, particularly with limited sampling. This article aids the pathologist by reviewing the hematologic differential diagnosis of a pediatric mediastinal mass, along with
Autor:
Mohammed Khashab, Mahmood A Qoqandi, Mohamed Elkhalifa, Alaa T Alsharif, Abdulaziz AlDakhil, Abeer M Alahmadi, Mohammed Alshehri
Publikováno v:
Cureus.
Publikováno v:
Cureus. 14(8)
Facial seborrheic dermatitis (SD) is a chronic inflammatory skin condition that can affect the quality of life with frequent recurrences. There is no medication as yet to cure this disease completely. There are four general categories of agents that
Autor:
Sharmila Raghunandan, Melinda Pauly, William G Blum, Muna Qayed, Madhav V Dhodapkar, Mohamed Elkhalifa, Benjamin Watkins, Michelle Schoettler, Edwin Horwitz, Suhag Parikh, Shanmuganathan Chandrakasan, Kathryn Leung, Elyse Bryson, Laura Deeb, Jonathan L Kaufman, Diana Worthington-White, Adina Alazraki, Jordan M Schecter, Deepu Madduri, Carolyn C Jackson, Enrique Zudaire, Agne Taraseviciute-Morris, Alexander Babich, Tonia Nesheiwat, Martin Vogel, Nikoletta Lendvai, Lida Pacaud, Kirsten M Williams
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006684
Plasmablastic lymphoma (PBL) is a rare subtype of aggressive large B-cell lymphoma, with a dismal prognosis despite aggressive therapies. New approaches are needed for those with refractory disease. PBL expresses antigens similar to multiple myeloma